Author:
Wu Fang,Mousa Youssef,Jereb Rebeka,Batchelor Hannah,Chakraborty Sumon,Heimbach Tycho,Stier Ethan,Kesisoglou Filippos,Kollipara Sivacharan,Zhang Lei,Zhao Liang
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Owens K, Argon S, Yu J, Yang X, Wu F, Lee SC, et al. Exploring the relationship of drug BCS classification, food effect, and gastric pH-dependent drug interactions. AAPS J. 2021;24(1):16.
2. U.S. Food and Drug Administration. Product specific guidance on palbociclib tablet. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_212436.pdf. Assessed 12 Dec 2023.
3. Dong Z, Li J, Wu F, Zhao P, Lee SC, Zhang L, et al. Application of physiologically-based pharmacokinetic modeling to predict gastric pH-dependent drug-drug interactions for weak base drugs. CPT Pharmacom Syst Pharmacol. 2020;9(8):456–65.
4. U.S. Food and Drug Administration. The Use of physiologically based pharmacokinetic analyses – biopharmaceutics applications for oral drug product development, manufacturing changes, and controls. Guidance for Industry. Draft. 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-physiologically-based-pharmacokinetic-analyses-biopharmaceutics-applications-oral-drug-product. Assessed 12 Dec 2023.
5. Cheng L, Wong H. Food effects on oral drug absorption: application of physiologically-based pharmacokinetic modeling as a predictive tool. Pharmaceutics. 2020;12(7):672.